课题基金 / 基金详情

Blood-brain barrier changes via hypoxia/re-oxygenation

Blood-brain barrier changes via hypoxia/re-oxygenation
缺氧/复氧导致血脑屏障发生变化
批准号:
6640460
负责人:
KEN A WITT
金额:
$4.64万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
未结题
起止时间:
2002-09-30 至

项目摘要

项目成果

KEN A WITT的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Ischemia associated pathologies (cardiac arrest, stroke, asphyxiation, etc.) significantly contribute to death and long-term disability in the United States. However, little is understood in regards to how the ischemic event induces a breakdown and increased permeability of the blood-brain barrier (BBB). Although hypoxia associated with stroke and cardiac arrest has been reported to cause increased BBB permeability, effects of re-oxygenation on brain endothelial cells following a hypoxic insult remains unclear, and what is known revolves solely around in vitro modeling. The hypothesis of this proposal is hypoxia / re-oxygenation induces significant alterations in the expression and localization of junctional and cytoskeletal proteins leading to increased BBB permeability. This proposal expands previous work on hypoxic insult to the BBB by focusing on functional, biochemical and molecular changes in brain endothelial cells during hypoxia / reoxygenation, in a whole animal model. Changes in BBB permeability, alterations in cytoskeletal I tight junction proteins, and distribution I localization of those proteins will be examined in this pathology. Data from this research will demonstrate how alterations in the cytoskeletal framework and junctional proteins are related to functional changes (i.e. paracellular permeability) that occur during hypoxia I re-oxygenation. The insight into the cellular mechanism, which occur over the time course of the pathology, will contribute to the development of alternative therapeutic strategies for the treatment of ischemia and associated brain alterations.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Lead optimization of somatostatin-based therapeutic for Alzheimer's Disease
Lead optimization of somatostatin-based therapeutic for Alzheimer's Disease
Lead optimization of somatostatin-based therapeutic for Alzheimer's Disease
Dietary impact on blood-brain barrier tight junctions
海外基金